NCT04996732 Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
| NCT ID | NCT04996732 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fudan University |
| Condition | Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 500,000 participants |
| Start Date | 2008-01-01 |
| Primary Completion | 2040-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500,000 participants in total. It began in 2008-01-01 with a primary completion date of 2040-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Real-world studies on long-term prognosis in patients who underwent anti-tumor treatments during hospitalization from a hospital-based cancer registry in china.
Eligibility Criteria
Inclusion Criteria: * All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period. Exclusion Criteria: * Patients who have not been treated during hospitalization; * Patients with non-malignant tumors.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04996732 clinical trial?
This trial is open to participants of all sexes, studying Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04996732 currently recruiting?
Yes, NCT04996732 is actively recruiting participants. Contact the research team at zhengying@fudan.edu.cn for enrollment information.
Where is the NCT04996732 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04996732 clinical trial?
NCT04996732 is sponsored by Fudan University. The trial plans to enroll 500,000 participants.